Bonesupport Holding AB (publ) (BOEUF) Stock

About Bonesupport Holding AB (publ)

Bonesupport Holding AB (publ) is an orthobiologics firm that develops and commercializes injectable bioceramic solutions designed to treat bone voids. These products are distributed across Europe, North America, and globally. The company's portfolio includes CERAMENT Bone Void Filler, a synthetic material that can be injected, molded, and drilled, containing hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol for visibility. They also offer CERAMENT G, a ceramic bone graft substitute infused with gentamicin, and CERAMENT V, a synthetic bone void filler containing vancomycin. Beyond its existing offerings, Bonesupport engages in preclinical development of products aimed at promoting bone regrowth. This research focuses on areas such as trauma, revision joint replacement surgeries, chronic osteomyelitis, oncology, and bone and foot infections associated with diabetes. Established in 1999, the company is headquartered in Lund, Sweden.

Bonesupport Holding AB (publ) is headquartered in SE.

Bonesupport Holding AB (publ) (BOEUF) stock trades at $20.49 with a market capitalization of $1.34B. The stock is valued at a price-to-earnings (P/E) ratio of 64.38, price-to-book of 14.47, price-to-sales of 10.62. Over the past 52 weeks the stock has ranged between $18.57 and $35.00, and currently trades 41.5% below its 52-week high.

On profitability, Bonesupport Holding AB (publ) generates a return on equity (ROE) of 23.82% — well above the market average, a sign of a high-quality business, return on capital employed of 32.76%, an operating margin of 24.28%, a net profit margin of 16.63%.

Official website: www.bonesupport.com